DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 076703
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
NDA 076703 describes DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION), which is a drug marketed by Apotex Inc, Sun Pharm, and Zydus Pharms, and is included in three NDAs. It is available from three suppliers. Additional details are available on the DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION) profile page.
The generic ingredient in DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION) is desmopressin acetate. There are twenty drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the desmopressin acetate profile page.
The generic ingredient in DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION) is desmopressin acetate. There are twenty drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the desmopressin acetate profile page.
Summary for 076703
| Tradename: | DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION) |
| Applicant: | Apotex Inc |
| Ingredient: | desmopressin acetate |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SPRAY, METERED;NASAL | Strength | 0.01MG/SPRAY | ||||
| Approval Date: | Jan 27, 2005 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
